You have 9 free searches left this month | for more free features.

Parosmia

Showing 1 - 25 of 189

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Parosmia Trial in London (Stellate Ganglion Block, Placebo)

Not yet recruiting
  • Parosmia
  • Stellate Ganglion Block
  • Placebo
  • London, Ontario, Canada
    St. Joseph's Hospital London
Sep 22, 2023

Triggers for Post-Viral Parosmia

Suspended
  • Parosmia
  • Smell Disorder
    • Reading, United Kingdom
      University of Reading
    Sep 5, 2021

    Hyposmia, COVID-19, Parosmia Trial in Trois-Rivières (Smell training)

    Recruiting
    • Hyposmia
    • +4 more
    • Smell training
    • Trois-Rivières, Quebec, Canada
      Université du Québec à Trois-Rivières
    May 20, 2022

    COVID-19-Associated Olfactory Dysfunction, Anosmia, Hyposmia Trial (Stellate Ganglion Block)

    Completed
    • Anosmia
    • +3 more
    • Stellate Ganglion Block
    • Saint Louis, Missouri
      Washington University School of Medicine/Barnes Jewish Hospital
    Jan 5, 2023

    COVID-19, Olfactory Disorder, Anosmia Trial in Saint Louis (Gabapentin gelatin capsules 300mg, Placebo)

    Enrolling by invitation
    • COVID-19
    • +4 more
    • Gabapentin gelatin capsules 300mg
    • Placebo
    • Saint Louis, Missouri
      Washington University
    Jun 16, 2022

    Anosmia, Covid19, Hyposmia Trial in Roma (co-ultraPEALut, Olfactory Rehab)

    Completed
    • Anosmia
    • +4 more
    • co-ultraPEALut
    • +3 more
    • Roma, Italy
      Multicentric
    Nov 12, 2022

    Hyposmia Trial in Solna (Nose plug, Regular olfactory training)

    Recruiting
    • Hyposmia
    • Nose plug
    • Regular olfactory training
    • Solna, Stockholm, Sweden
      Karolinska Institutet
    Nov 16, 2023

    Smell Dysfunction, Taste Disorders, Taste Disorder, Secondary, Sweet Trial (Insulin aspart)

    Not yet recruiting
    • Smell Dysfunction
    • +4 more
    • Insulin aspart
    • (no location specified)
    Oct 30, 2021

    Anosmia Trial (platelets rich plasma)

    Not yet recruiting
    • Anosmia
    • platelets rich plasma
    • (no location specified)
    May 25, 2022

    Smell Dysfunction, Olfactory Disorder, Long COVID Trial (Trigeminal Nerve Stimulation (TNS), Active Smell Training (ST), Placebo

    Not yet recruiting
    • Smell Dysfunction
    • +2 more
    • Trigeminal Nerve Stimulation (TNS)
    • +2 more
    • (no location specified)
    May 9, 2023

    Covid19, SARS-CoV Infection, Corona Virus Infection Trial in London (SARS-CoV-2 Virus, Remdesivir)

    Completed
    • Covid19
    • +4 more
    • London, United Kingdom
    • +1 more
    Jul 27, 2022

    Covid19, Anosmia, Olfactory Disorder Trial in Saint Louis (Theophylline Powder)

    Completed
    • Covid19
    • +7 more
    • Theophylline Powder
    • Saint Louis, Missouri
      Washington University School of Medicine in Saint Louis
    Feb 1, 2022

    Hyperkalemia Trial in Worldwide (Patiromer)

    Terminated
    • Hyperkalemia
    • Palo Alto, California
    • +29 more
    Oct 17, 2022

    COVID-19 Trial in Copenhagen (Olfactory training with essential oils, Olfactory training with fragrance-free oils)

    Recruiting
    • COVID-19
    • Olfactory training with essential oils
    • Olfactory training with fragrance-free oils
    • Copenhagen, Denmark
      Department of Otorhinolaryngology, Head and Neck Surgery & Audio
    Sep 13, 2022

    Anosmia, Covid19 Trial in New York (Omega-3 Fatty Acid Supplement, Placebo/Control)

    Completed
    • Anosmia
    • Covid19
    • Omega-3 Fatty Acid Supplement
    • Placebo/Control
    • New York, New York
      Mount Sinai Hospital
    Jan 14, 2022

    SARS-CoV-2 Acute Respiratory Disease Trial in Paris (Clinical examination, Blood collection, Olfactory evoked potentials)

    Recruiting
    • SARS-CoV-2 Acute Respiratory Disease
    • Clinical examination
    • +6 more
    • Paris, France
      Hôpital Lariboisière
    Aug 16, 2022

    Type 2 Diabetes Trial in Lakewood (Bexagliflozin)

    Completed
    • Type 2 Diabetes Mellitus
    • Lakewood, Colorado
      Denver Clinical Research Unit
    May 26, 2021

    Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via

    Terminated
    • Graves' Ophthalmopathy (GO)
    • RVT-1401 (Administered via subcutaneous injection)
    • Placebo (Administered via subcutaneous injection)
    • Beverly Hills, California
    • +24 more
    Aug 26, 2022

    COVID-19 Trial in Worldwide (AZD7442, Placebo)

    Completed
    • COVID-19
    • Jasper, Alabama
    • +102 more
    Jan 14, 2023

    Gout Trial in United States (biological, drug, dietary supplement)

    Completed
    • Gout
    • Pegloticase
    • +4 more
    • Anchorage, Alaska
    • +5 more
    Apr 27, 2021

    Hemorrhagic Hereditary Telangiectasia (HHT) Trial in Bron, Clermont-Ferrand, Montpellier (Protopic® (Tacrolimus) 0.1% ointment,

    Completed
    • Hemorrhagic Hereditary Telangiectasia (HHT)
    • Protopic® (Tacrolimus) 0.1% ointment
    • Placebo
    • Bron, France
    • +2 more
    Jun 12, 2020

    Malignant Pleural Mesothelioma Trial in Worldwide (MORAb-009 (Amatuximab), Pemetrexed, Cisplatin)

    Completed
    • Malignant Pleural Mesothelioma
    • MORAb-009 (Amatuximab)
    • +2 more
    • Birmingham, Alabama
    • +27 more
    Aug 24, 2022

    Cocaine Dependence Trial in United States (Buprenorphine + Naltrexone, Placebo + Naltrexone)

    Completed
    • Cocaine Dependence
    • Buprenorphine + Naltrexone
    • Placebo + Naltrexone
    • Los Angeles, California
    • +10 more
    Oct 1, 2021

    Menopause Hot Flashes Trial in United States (MT-8554 1mg, MT-8554 5mg, MT-8554 10mg)

    Completed
    • Menopause Hot Flashes
    • MT-8554 1mg
    • +3 more
    • Birmingham, Alabama
    • +62 more
    Dec 6, 2021

    Coronavirus, Covid19, SARS-CoV-2 Trial in Brussels, Liège (CVnCoV Vaccine)

    Terminated
    • Coronavirus
    • +3 more
    • CVnCoV Vaccine
    • Brussels, Belgium
    • +3 more
    Apr 20, 2022